EA201591098A1 - Бициклические пиримидиновые соединения - Google Patents

Бициклические пиримидиновые соединения

Info

Publication number
EA201591098A1
EA201591098A1 EA201591098A EA201591098A EA201591098A1 EA 201591098 A1 EA201591098 A1 EA 201591098A1 EA 201591098 A EA201591098 A EA 201591098A EA 201591098 A EA201591098 A EA 201591098A EA 201591098 A1 EA201591098 A1 EA 201591098A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyrimidine compounds
bicyclic pyrimidine
group
compounds
bicyclic
Prior art date
Application number
EA201591098A
Other languages
English (en)
Other versions
EA025106B1 (ru
Inventor
Томас Джеймс Бочамп
Ень Дао
Спенсер Брайан Джонс
Брайан Херст Норман
Ланс Аллен Пфайфер
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA201591098A1 publication Critical patent/EA201591098A1/ru
Publication of EA025106B1 publication Critical patent/EA025106B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)

Abstract

В изобретении предложены соединения формулы Iгде X представляет собой связь или CH; R выбран из группы, состоящей изкаждый Rи Rнезависимо выбран из группы, состоящей из СН и N; Rпредставляет собой Н или СН; Rпредставляет собой Н или СН; L выбран из группы, состоящей из -O(CH)-, -C(O)NH(CH)-, -CHC(O)NH(CH)-, -(CH)N(C(O)CH)CH-, -(CH)N(C(O)CH)CH-, -(CH)NH-, (CH)OCH-, -(CH)-, -(CH)NHCH-, -(CH)O- и -CHO(CH)-; или их фармацевтически приемлемые соли. Соединения согласно изобретению являются ингибиторами аутотаксина.
EA201591098A 2013-01-11 2014-01-07 Бициклические пиримидиновые соединения EA025106B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361751363P 2013-01-11 2013-01-11
US201361777201P 2013-03-12 2013-03-12
PCT/US2014/010400 WO2014110000A1 (en) 2013-01-11 2014-01-07 Pyrido- or pyrrolo-fused pyrimidine derivatives as autotaxin inhibitors for treating pain

Publications (2)

Publication Number Publication Date
EA201591098A1 true EA201591098A1 (ru) 2015-11-30
EA025106B1 EA025106B1 (ru) 2016-11-30

Family

ID=50031555

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201591098A EA025106B1 (ru) 2013-01-11 2014-01-07 Бициклические пиримидиновые соединения

Country Status (13)

Country Link
US (1) US8969555B2 (ru)
EP (1) EP2943494B1 (ru)
JP (1) JP6285461B2 (ru)
KR (1) KR101757997B1 (ru)
CN (1) CN104903327B (ru)
AU (1) AU2014205642B2 (ru)
BR (1) BR112015015812A2 (ru)
CA (1) CA2893253C (ru)
EA (1) EA025106B1 (ru)
ES (1) ES2636248T3 (ru)
MX (1) MX2015008971A (ru)
TW (1) TWI499591B (ru)
WO (1) WO2014110000A1 (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201500356A (zh) * 2013-04-12 2015-01-01 Lilly Co Eli 二氫吡啶并嘧啶化合物
KR102367876B1 (ko) 2013-11-22 2022-02-24 사브레 테라퓨틱스 엘엘씨 오토탁신 억제제 화합물
US9051320B1 (en) 2014-08-18 2015-06-09 Pharmakea, Inc. Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor
GB201501870D0 (en) 2015-02-04 2015-03-18 Cancer Rec Tech Ltd Autotaxin inhibitors
GB201502020D0 (en) 2015-02-06 2015-03-25 Cancer Rec Tech Ltd Autotaxin inhibitory compounds
EP4026549A1 (en) 2015-05-27 2022-07-13 Sabre Therapeutics LLC Autotaxin inhibitors and uses thereof
EP3302465A1 (en) 2015-06-05 2018-04-11 Vertex Pharmaceuticals Incorporated Triazoles for the treatment of demyelinating diseases
WO2018106646A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Aminotriazoles for the treatment of demyelinating diseases
WO2018106643A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Heterocyclic azoles for the treatment of demyelinating diseases
WO2018106641A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Pyrazoles for the treatment of demyelinating diseases
KR101798840B1 (ko) 2017-05-17 2017-11-17 주식회사 레고켐 바이오사이언스 신규 오토탁신 저해 화합물 및 이를 함유하는 약제학적 조성물
US10961242B2 (en) 2017-05-17 2021-03-30 Legochem Biosciences, Inc. Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same
CN110526929A (zh) * 2018-05-24 2019-12-03 广州市恒诺康医药科技有限公司 芳杂环化合物、其药物组合物及其应用
CA3106641A1 (en) * 2018-07-16 2020-01-23 The Scripps Research Institute Opioid haptens, conjugates, vaccines, and methods of generating antibodies
EP3919498A4 (en) * 2019-02-01 2022-09-28 Wuhan Humanwell Innovative Drug Research and Development Center Limited Company PYRAZOLOPYRIMIDI DERIVATIVE AND USE THEREOF
CN112457296B (zh) * 2019-09-06 2023-11-07 武汉人福创新药物研发中心有限公司 嘧啶类化合物及其制备方法
CA3150700A1 (en) * 2019-09-17 2021-03-25 Renato T. Skerlj IMIDAZOLE SUBSTITUTE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
CN112778334B (zh) * 2019-11-07 2022-04-15 广州市恒诺康医药科技有限公司 芳杂环化合物、其药物组合物及其应用
JP2023505419A (ja) * 2019-12-11 2023-02-09 スーチョワン ハイスコ ファーマスーティカル カンパニー リミテッド 含窒素ヘテロ環式オートタキシン阻害薬及びそれを含有する組成物並びにその使用
WO2022022570A1 (zh) * 2020-07-28 2022-02-03 武汉人福创新药物研发中心有限公司 含氮杂环化合物的盐及其盐的固体形式、药物组合物和用途
WO2022022569A1 (zh) * 2020-07-28 2022-02-03 武汉人福创新药物研发中心有限公司 含氮杂环化合物的固体形式及其药物组合物和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SV2002000205A (es) 1999-11-01 2002-06-07 Lilly Co Eli Compuestos farmaceuticos ref. x-01095
EP1552842A1 (en) 2002-06-07 2005-07-13 Kyowa Hakko Kogyo Co., Ltd. Bicyclic pyrimidine derivatives
DE102004020908A1 (de) 2004-04-28 2005-11-17 Grünenthal GmbH Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen
MX2007013595A (es) * 2005-05-04 2008-01-24 Renovis Inc Compuestos heterociclicos fusionados y composiciones y usos de estos.
EP2352732B1 (en) * 2008-12-01 2013-02-20 Merck Patent GmbH 2,5-DIAMINO-SUBSTITUTED PYRIDO[4, 3-d]PYRIMIDINES AS AUTOTAXIN INHIBITORS AGAINST CANCER
WO2012009258A2 (en) * 2010-07-13 2012-01-19 Edward Roberts Peptidomimetic galanin receptor modulators
WO2012024620A2 (en) 2010-08-20 2012-02-23 Amira Pharmaceuticals, Inc. Autotaxin inhibitors and uses thereof
AR084515A1 (es) * 2010-12-22 2013-05-22 Merz Pharma Gmbh & Co Kgaa Derivados heterociclicos nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades asociadas al sistema nervioso central tales como parkinson y alzheimer, entre otras
WO2013054185A1 (en) * 2011-10-13 2013-04-18 Pfizer, Inc. Pyrimidine and pyridine derivatives useful in therapy
IN2014DN03063A (ru) * 2011-10-28 2015-05-15 Inhibitaxin Ltd
TW201520219A (zh) * 2013-03-12 2015-06-01 Lilly Co Eli 咪唑並吡啶化合物
TW201500356A (zh) * 2013-04-12 2015-01-01 Lilly Co Eli 二氫吡啶并嘧啶化合物

Also Published As

Publication number Publication date
JP2016505010A (ja) 2016-02-18
CN104903327A (zh) 2015-09-09
MX2015008971A (es) 2015-09-28
AU2014205642A1 (en) 2015-07-02
CA2893253C (en) 2017-11-28
EP2943494B1 (en) 2017-02-22
EP2943494A1 (en) 2015-11-18
JP6285461B2 (ja) 2018-02-28
CN104903327B (zh) 2016-09-07
TW201437209A (zh) 2014-10-01
KR20150092761A (ko) 2015-08-13
AU2014205642B2 (en) 2016-02-25
EA025106B1 (ru) 2016-11-30
KR101757997B1 (ko) 2017-07-13
TWI499591B (zh) 2015-09-11
BR112015015812A2 (pt) 2017-07-11
ES2636248T3 (es) 2017-10-05
US20140200231A1 (en) 2014-07-17
US8969555B2 (en) 2015-03-03
WO2014110000A1 (en) 2014-07-17
CA2893253A1 (en) 2014-07-17

Similar Documents

Publication Publication Date Title
EA201591098A1 (ru) Бициклические пиримидиновые соединения
CY1121694T1 (el) Ενωσεις δι-κυκλικου-συντηγμενου ετεροαρυλιου ή αρυλιου και η χρηση αυτων ως αναστολεις irak4
CY1120705T1 (el) Καινοφανεις αναστολεις αποακετυλασων ιστονων
EA201891024A1 (ru) Соединения-ингибиторы tank-связывающей киназы
EA201591486A1 (ru) Соединения имидазопиридина
EA201490949A1 (ru) Ингибиторы киназ
EA201691799A1 (ru) Бициклические соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
CR20150418A (es) Compuestos de tetrahidropirrolotiazina
EA201692203A1 (ru) Соединения, ингибирующие tank-связывающую киназу
AR095039A1 (es) Inhibidores quinazolínicos de formas mutadas activantes del receptor del factor de crecimiento epidérmico
EA201691625A1 (ru) Ароматические гетероциклические соединения как противовоспалительные соединения
EA201591634A1 (ru) Дигидропиридопиримидиновые соединения
EA201590224A1 (ru) Имидазотриазинкарбонитрилы, используемые в качестве ингибиторов киназы
EA201791684A1 (ru) Селективные ингибиторы bace1
CY1117688T1 (el) Ενωσεις τετραϋδροπυρρολοθειαζινης
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
RS54730B1 (sr) Inhibitori beta sekretaze
EA201590319A1 (ru) Новые бициклические пиридиноны
EA201591360A1 (ru) Азабензимидазолы в качестве ингибиторов изозимов фдэ4 для лечения цнс и других расстройств
CL2019001694A1 (es) Compuestos de pirazolopirimidina y métodos de uso de los mismos.
EA201690911A1 (ru) Соединения диметилбензойной кислоты
MX2015017156A (es) Inhibidores de bace.
EA201400047A1 (ru) Производные n-оксипиразолотриазиндион
CO2019005165A2 (es) Compuesto de piridona como inhibidor de c-met
CY1125355T1 (el) Πεντακυκλικη ενωση

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU